ArticleBMC neurology2022

Opicapone versus placebo in the treatment of Parkinson's disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial.

K Ray Chaudhuri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.